Glonghui, December 4, Huabang Health (002004.SZ) said on an interactive platform that for a long time, the company has set up 3-5 products on a rolling basis every year to ensure product iteration and new product research and development, thus achieving full coverage of dermatologic drugs. In terms of innovative drugs, the company and participating company Pregin are collaborating to develop a novel nanoantibody drug to treat psoriasis, which is currently in the pre-clinical research stage.
华邦健康(002004.SZ)：正在研发主治银屑病的新型纳米抗体药物，目前处于临床前研究阶段
Huabang Health (002004.SZ): A novel nanoantibody drug for psoriasis is being developed and is currently in the pre-clinical research stage
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.